1. Home
  2. VVOS vs ICU Comparison

VVOS vs ICU Comparison

Compare VVOS & ICU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vivos Therapeutics Inc.

VVOS

Vivos Therapeutics Inc.

HOLD

Current Price

$2.26

Market Cap

17.7M

Sector

Health Care

ML Signal

HOLD

Logo SeaStar Medical Holding Corporation

ICU

SeaStar Medical Holding Corporation

HOLD

Current Price

$2.47

Market Cap

15.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VVOS
ICU
Founded
2016
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.7M
15.9M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
VVOS
ICU
Price
$2.26
$2.47
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$6.25
N/A
AVG Volume (30 Days)
129.8K
113.4K
Earning Date
11-19-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$17,317,000.00
$881,000.00
Revenue This Year
$17.96
$691.85
Revenue Next Year
$55.64
$64.17
P/E Ratio
N/A
N/A
Revenue Growth
18.76
1195.59
52 Week Low
$1.93
$2.20
52 Week High
$7.95
$30.70

Technical Indicators

Market Signals
Indicator
VVOS
ICU
Relative Strength Index (RSI) 51.67 88.76
Support Level $1.94 $0.22
Resistance Level $2.69 $2.81
Average True Range (ATR) 0.14 0.08
MACD 0.06 0.27
Stochastic Oscillator 41.18 85.66

Price Performance

Historical Comparison
VVOS
ICU

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

About ICU SeaStar Medical Holding Corporation

SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.

Share on Social Networks: